Cutaneous allodynia in the migraine population

Ann Neurol. 2008 Feb;63(2):148-58. doi: 10.1002/ana.21211.

Abstract

Objective: To develop and validate a questionnaire for assessing cutaneous allodynia (CA), and to estimate the prevalence and severity of CA in the migraine population.

Methods: Migraineurs (n = 11,388) completed the Allodynia Symptom Checklist, assessing the frequency of allodynia symptoms during headache. Response options were never (0), rarely (0), less than 50% of the time (1), > or = 50% of the time (2), and none (0). We used item response theory to explore how well each item discriminated CA. The relations of CA to headache features were examined.

Results: All 12 questions had excellent item properties. The greatest discrimination occurred with CA during "taking a shower" (discrimination = 2.54), wearing a necklace (2.39) or ring (2.31), and exposure to heat (2.1) or cold (2.0). The factor analysis demonstrated three factors: thermal, mechanical static, and mechanical dynamic. Based on the psychometrics, we developed a scale distinguishing no CA (scores 0-2), mild (3-5), moderate (6-8), and severe (> or = 9). The prevalence of allodynia among migraineurs was 63.2%. Severe CA occurred in 20.4% of migraineurs. CA was associated with migraine defining features (eg, unilateral pain: odds ratio, 2.3; 95% confidence interval, 2.0-2.4; throbbing pain: odds ratio, 2.3; 95% confidence interval, 2.1-2.6; nausea: odds ratio, 2.3; 95% confidence interval, 2.1-2.6), as well as illness duration, attack frequency, and disability.

Interpretation: The Allodynia Symptom Checklist measures overall allodynia and subtypes. CA affects 63% of migraineurs in the population and is associated with frequency, severity, disability, and associated symptoms of migraine. CA maps onto migraine biology.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Biomarkers / analysis
  • Cohort Studies
  • Comorbidity
  • Data Interpretation, Statistical
  • Disease Progression
  • Early Diagnosis
  • Female
  • Humans
  • Hyperalgesia / epidemiology*
  • Hyperalgesia / physiopathology
  • Male
  • Middle Aged
  • Migraine Disorders / diagnosis*
  • Migraine Disorders / epidemiology*
  • Migraine Disorders / physiopathology
  • Nociceptors / physiopathology*
  • Pain Measurement / methods*
  • Pain Threshold / physiology*
  • Predictive Value of Tests
  • Prognosis
  • Sensory Receptor Cells / physiopathology
  • Severity of Illness Index
  • Skin / innervation
  • Skin / physiopathology
  • Surveys and Questionnaires

Substances

  • Biomarkers